Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amgen research cuts buck top pharma trend

This article was originally published in Scrip

Executive Summary

Amgen has now confirmed that it is to reduce its research and development employees by some 380 positions. The number represents just over a 2% reduction in Amgen�s total workforce, but around 10% of those involved in R&D. However, those observers who have welcomed the cuts as a sign that Amgen is bringing its R&D commitments into line with pharma industry norms, may need to re-examine the industry-wide spending data.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts